Michael Bruce
Vorstandsvorsitzender bei Exo Therapeutics, Inc.
Profil
Michael Bruce is currently the Chief Executive Officer at Exo Therapeutics, Inc. Prior to this, he was the Senior Vice President of Development Operations at Kaleido Biosciences, Inc. from 2018 to 2020.
He was also the Senior VP of Program Portfolio & Alliance Management at CRISPR Therapeutics AG from 2015 to 2017.
Before that, he held the position of Vice President of Development Operations at Wyeth LLC from 2003 to 2015 and Vice President at Pfizer Inc. from 2003 to 2015.
Dr. Bruce holds a doctorate degree from Stanford University and an undergraduate degree from Williams College.
Aktive Positionen von Michael Bruce
| Unternehmen | Position | Beginn |
|---|---|---|
Exo Therapeutics, Inc.
 Exo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Exo Therapeutics, Inc. engages in production of drugs. It has developed a small-molecule enzyme inhibitor discovery platform that targets distal binding pockets of enzymes (exo-sites) that are not evolutionarily conserved. The company was founded by David R. Liu and Alan Saghatelian and is headquartered in Boston, MA. | Vorstandsvorsitzender | 01.02.2020 |
Ehemalige bekannte Positionen von Michael Bruce
| Unternehmen | Position | Ende |
|---|---|---|
| KALEIDO BIOSCIENCES, INC. | Corporate Officer/Principal | 01.02.2020 |
| CRISPR THERAPEUTICS AG | Corporate Officer/Principal | 01.01.2017 |
Wyeth Corp.
 Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Corporate Officer/Principal | 01.01.2015 |
| PFIZER, INC. | Corporate Officer/Principal | 01.01.2015 |
Ausbildung von Michael Bruce
| Williams College | Undergraduate Degree |
| Stanford University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| CRISPR THERAPEUTICS AG | Health Technology |
| KALEIDO BIOSCIENCES, INC. | Health Technology |
| PFIZER, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Wyeth Corp.
Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Health Technology |
Exo Therapeutics, Inc.
Exo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Exo Therapeutics, Inc. engages in production of drugs. It has developed a small-molecule enzyme inhibitor discovery platform that targets distal binding pockets of enzymes (exo-sites) that are not evolutionarily conserved. The company was founded by David R. Liu and Alan Saghatelian and is headquartered in Boston, MA. | Health Technology |
